Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions
Osteochondral Defect
Interventions
PROCEDURE

osteochondral transplant on the femoral condyle

Patients who have a symptomatic full-thickness cartilage lesion (Grade 3 or 4) on the femoral condyle, in a mechanically stable knee, or is being mechanically stabilized in the same procedure, between 2.0-8.0 cm2 in size, and cystic changes requiring osseous repair present in less than or equal to 12 mm of subchondral bone will undergo a osteochondral transplant by removing the damaged cartilage and replacing that cartilage with a cryopreserved osteochondral allograft core.

Trial Locations (6)

40506

RECRUITING

University of Kentucky Research Foundation, Lexington

60504

RECRUITING

Rush Copley Medical Center, Aurora

85006

RECRUITING

Banner- University Medical Center- Phoenix Orthopedic and Sports Medicine Institute, Phoenix

90045

NOT_YET_RECRUITING

Cedars-Sinai Kerlan Jobe Institute, Los Angeles

94063

RECRUITING

Stanford Medicine-Orthopaedics and Sports Medicine in Redwood City, Redwood City

94158

RECRUITING

University of California San Francisco, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AlloSource

INDUSTRY